Welcome to AMYPAD!

We were a collaborative research initiative aiming to improve the understanding, diagnosis and management of Alzheimer’s disease through the utilisation of ß-amyloid PET imaging.

The Amyloid imaging to prevent Alzheimer’s disease (AMYPAD) initiative aimed to:

 💡 You can now make a formal request to access our data!

 

→ Access data

 

→ Our papers

 

Homepage Image Neuraceq™ (left) and Vizamyl™ (right). Upper images: amyloid negative scans. Lower images: amyloid positive scans.
Latest News
New paper out proposing a novel continuous model of Aβ CSF/PET biomarker imbalance
New paper out proposing a novel continuous model of Aβ CSF/PET biomarker imbalance 13 Jun 2024 Discordance between CSF and PET biomarkers of β-amyloid (Aβ) might reflect an imbalance......
The Euro-PAD initiative holds a scientific symposium in Amsterdam
The Euro-PAD initiative holds a scientific symposium in Amsterdam 17 May 2024 The two-day event was marked by lively discussions......
Mahnaz Shekari defends her doctoral thesis, conducted at the BBRC
Mahnaz Shekari defends her doctoral thesis, conducted at the BBRC 12 Apr 2024 Huge congratulations to Mahnaz who successfully defended her doctoral thesis...
"We would hope that the direct results of the project are useful about our thinking of when amyloid deposition starts and when it's clinically relevant. But what is even more important is that the consortium that we formed, started collaborating on things that go well beyond the initial goals of AMYPAD. And actually, we should further integrate AMYPAD, EPAD and all the European cohorts that are now collaborating and joining forces in analysis of PET/MRI scans, imaging, biomarker but also genetic data. It is something of great value and will contribute to the future of all samples, definitely in Europe and hopefully also globally. ” Frederik Barkhof
Frederik Barkhof

AMYPAD Project Coordinator and Professor of Neuroradiology at VU University Medical Centre, Amsterdam and at University College London.